Ryan Zimmerman
Stock Analyst at BTIG
(4.16)
# 463
Out of 5,102 analysts
220
Total ratings
55.61%
Success rate
11.98%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SOLV Solventum | Upgrades: Buy | $100 | $82.79 | +20.79% | 2 | Dec 2, 2025 | |
| ALC Alcon | Reiterates: Buy | $91 | $78.76 | +15.54% | 13 | Nov 24, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $6 | $1.31 | +358.02% | 6 | Nov 21, 2025 | |
| GEHC GE HealthCare Technologies | Reiterates: Buy | $87 | $86.05 | +1.10% | 4 | Nov 21, 2025 | |
| ORGO Organogenesis Holdings | Maintains: Buy | $7 → $9 | $4.77 | +88.68% | 8 | Nov 20, 2025 | |
| RCEL AVITA Medical | Upgrades: Neutral | n/a | $3.53 | - | 4 | Nov 20, 2025 | |
| SYK Stryker | Reiterates: Buy | $410 | $352.97 | +16.16% | 18 | Nov 14, 2025 | |
| MDAI Spectral AI | Maintains: Buy | $3.5 → $3 | $1.72 | +74.42% | 2 | Nov 12, 2025 | |
| XTNT Xtant Medical Holdings | Maintains: Buy | $2 → $1.5 | $0.69 | +115.86% | 3 | Nov 11, 2025 | |
| TMCI Treace Medical Concepts | Downgrades: Neutral | n/a | $2.91 | - | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $24 | $13.12 | +82.93% | 1 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $122 → $112 | $92.45 | +21.15% | 9 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 | $28.23 | -0.81% | 5 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $104 → $116 | $109.23 | +6.20% | 14 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $18.33 | +25.48% | 10 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $320 | $311.40 | +2.76% | 20 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $529 → $589 | $547.36 | +7.61% | 21 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $74.83 | - | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $195 | $169.10 | +15.32% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $37.41 | - | 9 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $36.03 | - | 2 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $14.94 | +53.95% | 1 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $148 | $123.28 | +20.05% | 7 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $13.09 | - | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $88.88 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $14.05 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $24.68 | +114.75% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.71 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $15.71 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $141.28 | +41.56% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $294.17 | +18.98% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $99.75 | +28.32% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $11.53 | +30.10% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $19.26 | +118.07% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $4.82 | +989.21% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $29.98 | - | 3 | Apr 2, 2020 |
Solventum
Dec 2, 2025
Upgrades: Buy
Price Target: $100
Current: $82.79
Upside: +20.79%
Alcon
Nov 24, 2025
Reiterates: Buy
Price Target: $91
Current: $78.76
Upside: +15.54%
Humacyte
Nov 21, 2025
Reiterates: Buy
Price Target: $6
Current: $1.31
Upside: +358.02%
GE HealthCare Technologies
Nov 21, 2025
Reiterates: Buy
Price Target: $87
Current: $86.05
Upside: +1.10%
Organogenesis Holdings
Nov 20, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $4.77
Upside: +88.68%
AVITA Medical
Nov 20, 2025
Upgrades: Neutral
Price Target: n/a
Current: $3.53
Upside: -
Stryker
Nov 14, 2025
Reiterates: Buy
Price Target: $410
Current: $352.97
Upside: +16.16%
Spectral AI
Nov 12, 2025
Maintains: Buy
Price Target: $3.5 → $3
Current: $1.72
Upside: +74.42%
Xtant Medical Holdings
Nov 11, 2025
Maintains: Buy
Price Target: $2 → $1.5
Current: $0.69
Upside: +115.86%
Treace Medical Concepts
Nov 7, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.91
Upside: -
Nov 7, 2025
Maintains: Buy
Price Target: $21 → $24
Current: $13.12
Upside: +82.93%
Nov 5, 2025
Maintains: Buy
Price Target: $122 → $112
Current: $92.45
Upside: +21.15%
Nov 4, 2025
Upgrades: Buy
Price Target: $28
Current: $28.23
Upside: -0.81%
Oct 30, 2025
Maintains: Buy
Price Target: $104 → $116
Current: $109.23
Upside: +6.20%
Oct 29, 2025
Reiterates: Buy
Price Target: $23
Current: $18.33
Upside: +25.48%
Oct 27, 2025
Reiterates: Buy
Price Target: $320
Current: $311.40
Upside: +2.76%
Oct 22, 2025
Maintains: Buy
Price Target: $529 → $589
Current: $547.36
Upside: +7.61%
Oct 21, 2025
Reiterates: Neutral
Price Target: n/a
Current: $74.83
Upside: -
Oct 13, 2025
Maintains: Buy
Price Target: $190 → $195
Current: $169.10
Upside: +15.32%
Sep 17, 2025
Downgrades: Neutral
Price Target: n/a
Current: $37.41
Upside: -
Sep 16, 2025
Reiterates: Neutral
Price Target: n/a
Current: $36.03
Upside: -
Sep 9, 2025
Reiterates: Buy
Price Target: $23
Current: $14.94
Upside: +53.95%
Jul 14, 2025
Maintains: Buy
Price Target: $145 → $148
Current: $123.28
Upside: +20.05%
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $13.09
Upside: -
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $88.88
Upside: -
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $14.05
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $24.68
Upside: +114.75%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.71
Upside: -
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $15.71
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $141.28
Upside: +41.56%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $294.17
Upside: +18.98%
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $99.75
Upside: +28.32%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $11.53
Upside: +30.10%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $19.26
Upside: +118.07%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $4.82
Upside: +989.21%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $29.98
Upside: -